Brazil
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
26.67%
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
2 |
15.41%
|
Dec. 31, 2023 | USD 2.07 | -3.18% |
|
Brazil |
|
3 |
14.84%
|
Dec. 31, 2023 | USD 4.84 | -1.29% |
|
Brazil |
|
4 |
14.15%
|
Dec. 31, 2023 | USD 2.01 | 1.12% |
|
Brazil |
|
5 |
13.36%
|
Dec. 31, 2023 | USD 1.99 | 0.58% |
|
Brazil |
|
6 |
6.40%
|
Dec. 31, 2023 | USD 0.31 | -3.93% |
|
Brazil |
|
7 |
3.30%
|
Dec. 31, 2023 | USD 1.75 | -1.08% |
|
Brazil |
|
8 |
-61.36%
|
Dec. 31, 2023 | USD 1.67 | 1.07% |
|
Brazil |
The Biotechnology company in Brazil with the highest Operating Income Margin is Afya Limited (NasdaqGS: AFYA) at 26.67%.
The Biotechnology company in Brazil with the lowest Operating Income Margin is Biomm S.A. (São Paulo Stock Exchange: BIOM3.SA) at -61.36%.
The top 10 Biotechnology companies in Brazil by Operating Income Margin are Afya Limited, Blau Farmacêutica S.A., Rede D'Or São Luiz S.A., Fleury S.A., Baumer S.A., Diagnósticos da América S.A., Centro de Imagem Diagnósticos S.A. and Biomm S.A..
The bottom 10 Biotechnology companies in Brazil by Operating Income Margin are Biomm S.A., Centro de Imagem Diagnósticos S.A., Diagnósticos da América S.A., Baumer S.A., Fleury S.A., Rede D'Or São Luiz S.A., Blau Farmacêutica S.A. and Afya Limited.